Cognition Therapeutics, Inc. (CGTX) NASDAQ

0.63

-0.0039(-0.62%)

Updated at December 20 04:00PM

Currency In USD

Valuation

Market Cap55.47M
Enterprise Value26.79M
P/E Ratio-0.74
PEG Ratio0.23
Price/Sales Ratio70.37
Price/Book Ratio1.76
Enterprise/Revenue12.76
Enterprise/EBITDA-0.14

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-92.12
Operating Margin-157.08

Management Effectiveness

Return On Assets-1.24
Return On Equity-1.51

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit-252,000
EBITDA-25.51M
Net Income-25.79M
Diluted EPS-0.86

Balance Sheet

Total Cash22.01M
Total Cash/Share0.54
Total Debt580,000
Total Debt/Equity0.01
Current Ratio2.11
Book Value Per Share0.36

Price History

52-Week Change-62.94
52-Week High2.95
52-Week Low0.34
Moving Average 50 Days0.47
Moving Average 200 Days1.24

Statistics

Average Volume6.66M
Shares Outstanding41.55M
% Held by Institutions10.52

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A